| P50 | author | Christine Johnston | Q56501593 |
| | Keith R. Jerome | Q57904630 |
| | Hans-Peter Kiem | Q88408730 |
| P2093 | author name string | Joshua T Schiffer | |
| | Dobromir T Dimitrov | |
| P2860 | cites work | Sexual behaviour patterns in South Africa and their association with the spread of HIV: insights from a mathematical model | Q58293552 |
| | The duration of exposure to HIV modulates the breadth and the magnitude of HIV-specific memory CD4+ T cells | Q79485092 |
| | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
| | Targeted DNA mutagenesis for the cure of chronic viral infections | Q24620150 |
| | Prevention of HIV-1 infection with early antiretroviral therapy | Q24634688 |
| | Antiretroviral prophylaxis for HIV prevention in heterosexual men and women | Q28270788 |
| | Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies | Q28307869 |
| | Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1 | Q28655602 |
| | Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand | Q29547531 |
| | HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time | Q29547822 |
| | Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana | Q29620078 |
| | Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco | Q33604727 |
| | Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs | Q33604776 |
| | Infectious disease dynamics: What characterizes a successful invader? | Q33772296 |
| | AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein | Q34047774 |
| | Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection | Q34405543 |
| | Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies | Q34607763 |
| | Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples | Q35034154 |
| | Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance | Q35619584 |
| | Preparing for the availability of a partially effective HIV vaccine: some lessons from other licensed vaccines | Q36083061 |
| | Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model. | Q37006885 |
| | Antiretroviral therapy and pre-exposure prophylaxis: combined impact on HIV transmission and drug resistance in South Africa | Q37494332 |
| | Finding a cure for human immunodeficiency virus-1 infection | Q38256237 |
| | The natural history of HIV infection: implications for the assessment of antiretroviral therapy | Q40708013 |
| | Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes | Q40886843 |
| | The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis | Q42279773 |
| | HIV-1 prevention with ART and PrEP: mathematical modeling insights into resistance, effectiveness, and public health impact | Q42919016 |
| | A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy | Q44165805 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 22183 | |
| P577 | publication date | 2016-02-24 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population | |
| P478 | volume | 6 | |